أخبار السوق اليوم — عناوين الأسهم والعملات الرقمية المنتقاة بالذكاء الاصطناعي

Executives from major pharmaceutical companies, including Eli Lilly, Novo Nordisk, and Pfizer, anticipate significant growth in the obesity drug market, driven by increased availability, easier access, and potential combination therapies.

OpenAI and Anthropic are targeting enterprise customers, a significant portion of their business, as they expand their reach at the Davos conference.

U.S.

Maharashtra, one of India's most industrialized states, aims to attract more investments than last year at the Davos conference, solidifying its position as a top business destination.

Canaan, a leading bitcoin mining hardware manufacturer, reported a record $150M quarter, highlighted its new Avalon A16 miners, and showcased its growing bitcoin treasury, signaling a strong financial performance and strategic diversification.

Ascentage Pharma's CEO is optimistic about the company's partnership with Takeda, expecting a blood cancer therapy to be ready for commercialization within two years.

Novo Nordisk's CEO, Mike Doustdar, expressed confidence in the demand for the pill version of their obesity drug Wegovy in the US, indicating a strong market potential for the company.

Ceva, Inc.

Alnylam Pharmaceuticals' CEO Yvonne Greenstreet highlighted the company's development goals and its potential to reach profitability in the near future, indicating a positive outlook for the company's growth and financial performance.

Elanco Animal Health CEO Jeff Simmons highlights the company's focus on gaining market share through 'major' innovations in pet-care, cattle, and poultry sectors.

Zoetis CEO Kristin Peck attributes higher protein demand to increased demand for livestock vaccines, indicating a positive trend in the animal health sector.

Pfizer's CEO Albert Bourla expressed optimism about the company's weight-loss drug prospects, seeking 'superior' results, while also expressing satisfaction with the current portfolio.